What is the rationale for using a stepwise approach to chronic enteropathy?

• A. To efficiently identify FRD, ARE, or IRE and minimize invasive testing
• B. To randomly trial therapies
• C. To delay treatment
• D. To escalate to surgical intervention early

Answer: (A)

The idea behind a stepwise approach to chronic enteropathy is to classify the disease by how it responds to noninvasive treatments, starting with the least invasive option. Many chronic GI cases are food-responsive, so beginning with a diet trial can reveal a Food-Responsive Disease without needing further testing. If the animal improves on the diet, you’ve identified the cause and avoided invasive workups. If there’s no adequate response, you move to a course of antibiotics to detect Antibiotic-Responsive Enteropathy, again trying to guide treatment based on how the disease behaves. If no improvement occurs after that, you proceed to immunosuppressive therapy to address potential immune-mediated disease, with any necessary diagnostics like biopsies reserved for cases that don’t respond or require confirmation.

This approach minimizes invasive testing by using therapeutic trials as diagnostic clues. It’s not about randomly trying therapies, delaying treatment, or rushing to surgery; it’s about efficiently sorting out which category of disease the patient fits into through measured, noninvasive steps.